- Home
- ZVRA vs CYRX Comparison
ZVRA vs CYRX Comparison
Compare ZVRA & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZVRA | CYRX |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.9M | 419.3M |
| IPO Year | 2015 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ZVRA | CYRX |
|---|---|---|
| Price | $10.24 | $10.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $23.00 | $13.31 |
| AVG Volume (30 Days) | ★ 677.9K | 400.5K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 159.21 | 156.22 |
| EPS | 1.35 | ★ 1.40 |
| Revenue | $106,470,000.00 | ★ $176,177,000.00 |
| Revenue This Year | $37.27 | $11.06 |
| Revenue Next Year | $53.42 | $8.45 |
| P/E Ratio | $7.14 | ★ $6.99 |
| Revenue Growth | ★ 350.91 | N/A |
| 52 Week Low | $7.16 | $5.31 |
| 52 Week High | $13.16 | $11.45 |
Technical Indicators
Market Signals| Indicator | ZVRA | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 55.29 | 59.16 |
| Support Level | $8.25 | $9.18 |
| Resistance Level | $11.07 | $11.00 |
| Average True Range (ATR) | 0.39 | 0.39 |
| MACD | -0.05 | -0.05 |
| Stochastic Oscillator | 55.03 | 54.71 |
Price Performance
Historical ComparisonAbout ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.